Pricing Log in Create free account

Black Diamond Therapeutics, Inc. (BDTX) vs Immunic, Inc. (IMUX)

Black Diamond Therapeutics, Inc. and Immunic, Inc. are both Biotechnology companies. Black Diamond Therapeutics, Inc. and Immunic, Inc. are of similar size ($100.0M and $96.9M). Across the 8 metrics below, Black Diamond Therapeutics, Inc. leads on 7 and Immunic, Inc. on 1.

Valuation

Metric BDTX IMUX Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 1.03 2.32 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.23 n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (43.60%) (62.84%) (33.15%)
Free cash flow yield (33.25%) (29.71%) (25.50%)

Profitability

Metric BDTX IMUX Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (37.21%) (138.17%) (56.36%)
Return on assets (29.21%) (101.15%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BDTX IMUX Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 130.71% 38.00% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BDTX IMUX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.28 5.05 4.72
Net debt to EBITDA (10.01) 0.15 0.96

Dividend

Metric BDTX IMUX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BDTX IMUX Biotechnology median
Market cap 99.97m 96.87m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack